Refine by
Clinical Trial Articles & Analysis: This-Year
2 articles found
In recent years, many peptide vaccines targeting viruses (such as HIV, hepatitis B, SARS-CoV-2), bacteria (such as Mycobacterium tuberculosis), and tumor antigens (such as MAGE-A1, HER2) are in clinical trial stages, some advancing to late-stage research, showing broad application prospects. ...
This approach has gained rapid attention across academia, biotech, and big pharma. Clinical Progress Preceding Academic Validation Interestingly, clinical development in in vivo CAR-T advanced before large-scale academic confirmation was published. In June 2025, Capstan Therapeutics announced the initiation of a Phase I clinical ...